Article Details
Retrieved on: 2024-04-29 16:45:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche RO added 0.50% after a European Medicines Agency committee recommended the approval of its multiple sclerosis drug Ocrevus' subcutaneous ...
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here